Q5153 Injection, aflibercept-yszy, 1 milligrams
Q-Codes
Also known as: aflibercept biosimilar, Vabysmo, anti-VEGF, VEGF inhibitor
Injection of aflibercept-yszy (Vabysmo), a biosimilar to aflibercept, administered at 1 milligram per dose.
Clinical Context
Used for diabetic macular edema and wet age-related macular degeneration. Administered as intravitreal injection for treatment of retinal vascular diseases.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.